解决罕见疾病药物开发的全球监管挑战
Enrico Costa1, Vijayalekshmi Ajith2, Ahmed F Al Khaldi3
1Italian Medicines Agency (AIFA), Rome, Italy.
Drug discovery today
|September 1, 2025
概括
监管灵活性有助于开发罕见病药物,但产生强有力的证据仍然是一个挑战. 关键的优先事项包括全球协调,验证的替代终点,患者的意见和有效的药物批准的数字健康工具.
科学领域:
- 监管科学
- 药物开发
- 罕见疾病
背景情况:
- 尽管有进展,但许多罕见疾病仍缺乏有效的治疗方法.
- 监管机构通过立法和加快流程支持罕见疾病研究.
- 在为罕见疾病治疗提供足够的证据方面仍然存在挑战.
研究的目的:
- 确定改善罕见疾病药物开发的优先事项.
- 为了平衡监管灵活性与不确定性管理.
- 探索新技术在罕见疾病治疗方面的作用.
主要方法:
- 分析目前罕见疾病药物开发的监管实践和挑战.
- 确定需要改进的关键领域.
- 审查新兴的数字健康技术和分散的试验方法.
主要成果:
- 主要优先事项包括建立全球监管语言.
- 识别和验证替代终点至关重要.
- 患者参与定义有意义的结果至关重要.
- 数字健康技术和分散的试验可以增强证据的产生和获取.
结论:
- 灵活性与不确定性管理之间的平衡对于罕见病药物的批准至关重要.
- 实施确定优先事项可以带来更有效和包容的发展过程.
- 在传统方法不足的情况下,需要利用创新工具.
相关概念视频
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Drug Control Governance: Regulatory Bodies and Their Impact
240
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
240
Prescription, Nonprescription and Orphan Drugs
842
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
842
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K


